✦ LIBER ✦

Dabrafenib and Trametinib, Alone and in Combination for BRAF-Mutant Metastatic Melanoma

✍ Scribed by Menzies, A. M.; Long, G. V.

Book ID: 125482573
Publisher: American Association for Cancer Research
Year: 2014
Tongue: English
Weight: 348 KB
Volume: 20
Category: Article
ISSN: 1078-0432
DOI: 10.1158/1078-0432.CCR-13-2054

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical development of dabrafenib in BR

Clinical development of dabrafenib in BRAF mutant melanoma and other malignancies

✍ Gibney, Geoffrey T; Zager, Jonathan S 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 277 KB

Cutaneous manifestations of dabrafenib (

Cutaneous manifestations of dabrafenib (GSK2118436): a selective inhibitor of mutant BRAF in patients with metastatic melanoma

✍ Anforth, R.M.; Blumetti, T.C.M.P.; Kefford, R.F.; Sharma, R.; Scolyer, R.A.; Kos 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 564 KB

Combined BRAF and MEK Inhibition versus

Combined BRAF and MEK Inhibition versus BRAF Inhibition Alone in Melanoma

✍ Long, Georgina V.; Stroyakovskiy, Daniil; Gogas, Helen; Levchenko, Evgeny; de Br 📂 Article 📅 2014 🏛 Massachusetts Medical Society 🌐 English ⚖ 570 KB

Unpicking the Combination Lock for Mutan

Unpicking the Combination Lock for Mutant BRAF and RAS Melanomas

✍ Al-Lazikani, B.; Workman, P. 📂 Article 📅 2013 🏛 American Association for Cancer Research 🌐 English ⚖ 850 KB

Targeting mutant BRAF and KIT in metasta

Targeting mutant BRAF and KIT in metastatic melanoma: ASCO 2009 meeting report

✍ Vernon K. Sondak; Keiran Smalley 📂 Article 📅 2009 🏛 Wiley (Blackwell Publishing) 🌐 English ⚖ 34 KB

Combining Targeted Therapy With Immunoth

Combining Targeted Therapy With Immunotherapy in BRAF-Mutant Melanoma: Promise and Challenges

✍ Hu-Lieskovan, S.; Robert, L.; Homet Moreno, B.; Ribas, A. 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 194 KB